305 related articles for article (PubMed ID: 20060165)
1. Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies.
Nakamura T; Lipton SA
Cell Calcium; 2010 Feb; 47(2):190-7. PubMed ID: 20060165
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2011 Apr; 14(8):1479-92. PubMed ID: 20812868
[TBL] [Abstract][Full Text] [Related]
4. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Gu Z; Nakamura T; Lipton SA
Mol Neurobiol; 2010 Jun; 41(2-3):55-72. PubMed ID: 20333559
[TBL] [Abstract][Full Text] [Related]
5. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
Nakamura T; Lipton SA
Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
[TBL] [Abstract][Full Text] [Related]
6. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
Nakamura T; Lipton SA
Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2008 Jan; 10(1):87-101. PubMed ID: 17961071
[TBL] [Abstract][Full Text] [Related]
8. Cell death: protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Apoptosis; 2009 Apr; 14(4):455-68. PubMed ID: 19130231
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases.
Prentice H; Modi JP; Wu JY
Oxid Med Cell Longev; 2015; 2015():964518. PubMed ID: 26576229
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor.
Stewart VC; Heslegrave AJ; Brown GC; Clark JB; Heales SJ
Eur J Neurosci; 2002 Feb; 15(3):458-64. PubMed ID: 11876773
[TBL] [Abstract][Full Text] [Related]
11. Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.
Nakamura T; Lipton SA
Trends Pharmacol Sci; 2016 Jan; 37(1):73-84. PubMed ID: 26707925
[TBL] [Abstract][Full Text] [Related]
12. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
Nakamura T; Lipton SA
Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
[TBL] [Abstract][Full Text] [Related]
13. Calpain inhibitors prevent nitric oxide-triggered excitotoxic apoptosis.
Volbracht C; Fava E; Leist M; Nicotera P
Neuroreport; 2001 Dec; 12(17):3645-8. PubMed ID: 11726766
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca(2+) influx.
Urushitani M; Nakamizo T; Inoue R; Sawada H; Kihara T; Honda K; Akaike A; Shimohama S
J Neurosci Res; 2001 Mar; 63(5):377-87. PubMed ID: 11223912
[TBL] [Abstract][Full Text] [Related]
15. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
Lipton SA
Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
[TBL] [Abstract][Full Text] [Related]
16. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
19. Brain oxidation is an initial process in sleep induction.
Ikeda M; Ikeda-Sagara M; Okada T; Clement P; Urade Y; Nagai T; Sugiyama T; Yoshioka T; Honda K; Inoué S
Neuroscience; 2005; 130(4):1029-40. PubMed ID: 15652998
[TBL] [Abstract][Full Text] [Related]
20. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
